Comparison of subjective cognitive decline and polygenic risk score in the prediction of all-cause dementia, Alzheimer’s disease and vascular dementia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Comparison of subjective cognitive decline and polygenic risk score in the prediction of all-cause dementia, Alzheimer’s disease and vascular dementia ; volume:16 ; number:1 ; day:19 ; month:8 ; year:2024 ; pages:1-12 ; date:12.2024
Alzheimer's research & therapy ; 16, Heft 1 (19.8.2024), 1-12, 12.2024
- Urheber
-
Trares, Kira
Stocker, Hannah
Stevenson-Hoare, Joshua
Perna, Laura
Holleczek, Bernd
Beyreuther, Konrad
Schöttker, Ben
Brenner, Hermann
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-024-01559-9
- URN
-
urn:nbn:de:101:1-2411052140428.924049559950
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
03.01.88025, 12:50 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Trares, Kira
- Stocker, Hannah
- Stevenson-Hoare, Joshua
- Perna, Laura
- Holleczek, Bernd
- Beyreuther, Konrad
- Schöttker, Ben
- Brenner, Hermann
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dementia / Alzheimer's Disease
Alzheimer’s Disease polygenic risk, the plasma proteome, and dementia incidence among UK older adults
Improved risk prediction of all-cause dementia, Alzheimer’s disease, and vascular dementia by biomarkers of oxidative stress and inflammation
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Microglial immunophenotype in dementia with Alzheimer’s pathology
Alzheimer’s disease, dementia, and stem cell therapy
Presenilins in Alzheimer’s disease and frontotemporal dementia
A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer’s disease
Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis
Plasma cholesterol in Alzheimer’s disease and frontotemporal dementia
Multimodal deep learning for Alzheimer’s disease dementia assessment
Frailty in Older Adults with Mild Dementia: Dementia with Lewy Bodies and Alzheimer’s Disease
Dementia / Alzheimer's Disease
Alzheimer’s Disease polygenic risk, the plasma proteome, and dementia incidence among UK older adults
Improved risk prediction of all-cause dementia, Alzheimer’s disease, and vascular dementia by biomarkers of oxidative stress and inflammation
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Microglial immunophenotype in dementia with Alzheimer’s pathology
Alzheimer’s disease, dementia, and stem cell therapy
Presenilins in Alzheimer’s disease and frontotemporal dementia
A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer’s disease
Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis
Plasma cholesterol in Alzheimer’s disease and frontotemporal dementia
Multimodal deep learning for Alzheimer’s disease dementia assessment
Frailty in Older Adults with Mild Dementia: Dementia with Lewy Bodies and Alzheimer’s Disease
Dementia / Alzheimer's Disease
Alzheimer’s Disease polygenic risk, the plasma proteome, and dementia incidence among UK older adults
Improved risk prediction of all-cause dementia, Alzheimer’s disease, and vascular dementia by biomarkers of oxidative stress and inflammation
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Microglial immunophenotype in dementia with Alzheimer’s pathology
Alzheimer’s disease, dementia, and stem cell therapy
Presenilins in Alzheimer’s disease and frontotemporal dementia
A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer’s disease
Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis
Plasma cholesterol in Alzheimer’s disease and frontotemporal dementia
Multimodal deep learning for Alzheimer’s disease dementia assessment